BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 32609640)

  • 21. Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis.
    Liu W; Kou G; Dong Y; Zheng Y; Ding Y; Ni W; Wu W; Tang S; Xiong Z; Zhang Y; Liu L; Zheng S
    J Clin Virol; 2020 Sep; 130():104576. PubMed ID: 32763810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S
    J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
    Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
    J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.
    Liu W; Liu L; Kou G; Zheng Y; Ding Y; Ni W; Wang Q; Tan L; Wu W; Tang S; Xiong Z; Zheng S
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
    Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
    PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
    He Y; Luo J; Yang J; Song J; Wei L; Ma W
    Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value and Validity of Coronavirus Antibody Testing.
    Mahajan A; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
    Pflüger LS; Bannasch JH; Brehm TT; Pfefferle S; Hoffmann A; Nörz D; van der Meirschen M; Kluge S; Haddad M; Pischke S; Hiller J; Addo MM; Lohse AW; Schulze Zur Wiesch J; Peine S; Aepfelbacher M; Lütgehetmann M
    J Clin Virol; 2020 Sep; 130():104549. PubMed ID: 32763809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19.
    Imai K; Tabata S; Ikeda M; Noguchi S; Kitagawa Y; Matuoka M; Miyoshi K; Tarumoto N; Sakai J; Ito T; Maesaki S; Tamura K; Maeda T
    J Clin Virol; 2020 Jul; 128():104393. PubMed ID: 32387968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
    J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
    Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
    J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
    Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
    J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.
    Van Elslande J; Houben E; Depypere M; Brackenier A; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
    Clin Microbiol Infect; 2020 Aug; 26(8):1082-1087. PubMed ID: 32473953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.